91 related articles for article (PubMed ID: 29106709)
1. A new genetic background for the Jr(a-) blood group phenotype caused by the ABCG2*439T allele encoding a p.Arg147Trp change.
Wieckhusen C; Rink G; Scharberg EA; Rothenberger S; Stürtzel A; Richter E; Bugert P
Transfusion; 2017 Dec; 57(12):3063-3064. PubMed ID: 29106709
[No Abstract] [Full Text] [Related]
2. Two novel ABCG2 alleles resulting in a Jr(a-) phenotype.
Berardi P; Cote J; Vege S; Aeschlimann J; Cserti-Gazdewich C; Westhoff CM
Transfusion; 2017 Nov; 57(11):2811-2812. PubMed ID: 28836283
[No Abstract] [Full Text] [Related]
3. A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a-) phenotype.
Ogasawara K; Osabe T; Suzuki Y; Tsuneyama H; Isa K; Kawai M; Obara K; Ogiyama Y; Ito S; Uchikawa M; Satake M; Tadokoro K
Transfusion; 2015 Jun; 55(6 Pt 2):1467-71. PubMed ID: 25522810
[TBL] [Abstract][Full Text] [Related]
4. The JR blood group system: identification of alleles that alter expression.
Hue-Roye K; Zelinski T; Cobaugh A; Lomas-Francis C; Miyazaki T; Tani Y; Westhoff CM; Reid ME
Transfusion; 2013 Nov; 53(11):2710-4. PubMed ID: 23438071
[TBL] [Abstract][Full Text] [Related]
5. The JR blood group system (ISBT 032): molecular characterization of three new null alleles.
Hue-Roye K; Lomas-Francis C; Coghlan G; Zelinski T; Reid ME
Transfusion; 2013 Jul; 53(7):1575-9. PubMed ID: 23066723
[TBL] [Abstract][Full Text] [Related]
6. ABCG2 null alleles define the Jr(a-) blood group phenotype.
Zelinski T; Coghlan G; Liu XQ; Reid ME
Nat Genet; 2012 Jan; 44(2):131-2. PubMed ID: 22246507
[TBL] [Abstract][Full Text] [Related]
7. A review of the JR blood group system.
Castilho L; Reid ME
Immunohematology; 2013; 29(2):63-8. PubMed ID: 24094238
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes.
Haer-Wigman L; Ait Soussan A; Ligthart P; de Haas M; van der Schoot CE
Transfusion; 2014 Jul; 54(7):1836-46. PubMed ID: 24456066
[TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of Jr(a-) blood type-related ABCG2 variants: Arg147Trp and Ser572Arg disrupt the plasma membrane localization of ABCG2.
Toyoda Y; Matsuo H; Tanaka M; Stiburkova B; Takada T
Transfusion; 2024 Feb; 64(2):412-414. PubMed ID: 38379528
[No Abstract] [Full Text] [Related]
10. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.
Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H
Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995
[TBL] [Abstract][Full Text] [Related]
11. Deletion of Exons 3 through 5 of ABCG2 causes the Jr(a-) phenotype in a West African woman.
Saison C; Cartron JP; Arnaud L
Transfusion; 2015 Nov; 55(11):2766-7. PubMed ID: 26173500
[No Abstract] [Full Text] [Related]
12. An update on the JR blood group system.
Castilho L
Immunohematology; 2019 Jun; 35(2):43-44. PubMed ID: 31246485
[TBL] [Abstract][Full Text] [Related]
13. Defining the Jr(a-) phenotype in the Japanese population.
Tanaka M; Kamada I; Takahashi J; Kimura K; Matsukura H; Tani Y
Transfusion; 2014 Feb; 54(2):412-7. PubMed ID: 23713577
[TBL] [Abstract][Full Text] [Related]
14. [Molecular genetic analysis of two individuals with Bw subtypes of ABO variant].
Li GJ; Zhang X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Dec; 30(6):733-5. PubMed ID: 24327158
[TBL] [Abstract][Full Text] [Related]
15. ABCG2 in peptic ulcer: gene expression and mutation analysis.
Salagacka-Kubiak A; Żebrowska M; Wosiak A; Balcerczak M; Mirowski M; Balcerczak E
J Appl Genet; 2016 Aug; 57(3):335-42. PubMed ID: 26578453
[TBL] [Abstract][Full Text] [Related]
16. Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding.
Alqawi O; Bates S; Georges E
Biochem J; 2004 Sep; 382(Pt 2):711-6. PubMed ID: 15139851
[TBL] [Abstract][Full Text] [Related]
17. Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non-small-cell lung cancer.
Akasaka K; Kaburagi T; Yasuda S; Ohmori K; Abe K; Sagara H; Ueda Y; Nagao K; Imura J; Imai Y
Cancer Chemother Pharmacol; 2010 Sep; 66(4):691-8. PubMed ID: 20035425
[TBL] [Abstract][Full Text] [Related]
18. Association between the ABCG2 C421A polymorphism and Alzheimer's disease.
Fehér Á; Juhász A; László A; Pákáski M; Kálmán J; Janka Z
Neurosci Lett; 2013 Aug; 550():51-4. PubMed ID: 23827224
[TBL] [Abstract][Full Text] [Related]
19. Identification of residues in ABCG2 affecting protein trafficking and drug transport, using co-evolutionary analysis of ABCG sequences.
Haider AJ; Cox MH; Jones N; Goode AJ; Bridge KS; Wong K; Briggs D; Kerr ID
Biosci Rep; 2015 Jul; 35(4):. PubMed ID: 26294421
[TBL] [Abstract][Full Text] [Related]
20. Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti-Jr(a).
Fujita S; Kashiwagi H; Tomimatsu T; Ito S; Mimura K; Kanagawa T; Endo M; Miyoshi T; Okamura Y; Tani Y; Tomiyama Y; Kimura T
Transfusion; 2016 May; 56(5):1171-81. PubMed ID: 26868047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
